Sign in to continue:

Sunday, April 5th, 2026

Category: us corporate news

Aptose Biosciences 2025 Annual Report: Tuspetinib Clinical Development and Key Findings in AML Therapy

Detailed Investor Article: Aptose Biosciences 2025 Annual Re...

Streamex Corp. 2025 Annual Report: Nasdaq-Listed Electromedical Company Financial and Corporate Overview

Streamex Corp. 2025 Annual Report – Key Insights for Investo...

Progress Software Corp (PRGS) Q1 2026 Earnings Report: Revenue, Net Income, and Financial Highlights

Progress Software Corporation Q1 2026 Results: Key Insights ...

Taylor Devices, Inc. Reports Strong Q3 2026 Results with Higher Revenue and Net Income Growth

Taylor Devices, Inc. Q3 2026 Financial Report: Key Investor ...